May 28 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* EXECUTES 20 YEAR LICENSE AND SUPPLY AGREEMENT FOR NOVEL ORAL CONTRACEPTIVE IN AUSTRALIA
* EXPECTED TO BE FILED WITH THERAPEUTIC GOODS ADMINISTRATION (TGA) IN 2020 WITH POTENTIAL LAUNCH IN SECOND HALF OF CALENDAR 2021
* ON APPROVAL, PRODUCT IS EXPECTED TO RECEIVE FIVE YEARS OF DATA EXCLUSIVITY FROM TGA
* LICENSE & SUPPLY DEAL WITH MITHRA PHARMACEUTICALS SA TO COMMERCIALISE E4/DRSP